2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical
company he led until stepping down to run for United States Senate. To his right are
Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel
Evans/Associated

Press},identifier:100000006098011 Sba8b80411187, imageIdentifier:el26e7bde26613f
50f2609cb8776d827, layout: fullbleed-
image, role:photo, type:scalable image}, {identifier: anf-caption-

1,inlineTextStyles: [{range:{length:27, start :261},textStyle:photo-
credit}],layout:default-caption, role: caption, text:Bob Hugin spoke in 2014
at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company
he led until stepping down to run for United States Senate. To his right are
Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel

Evans/Associated Press ,type™:text}],identifier: anf-container-
5,layout™:image-
container, role:container, type: container}],identifier: anf-section-

2,layout:default-

section, role:section, scene: {fadeColor:#FFFFFF,type:fading sticky header}
,type™:section}, {additions: [{URL:https://www.businesswire.com/news/home/2018012
9005762/en/Celgene-Announces-Retirement-Executive-Chairman-Bob-

Hugin, range: {length:34, start :194},type:link}],identifier: anf-body-
6, inlineTextStyles:[{range: {length:363,start:0},textstyle: anf-ts-
I}, {range™: {length:363,start:0},textStyle:_anf-ts-1}],layout:default—

body, role:body, text:When Bob Hugin joined Celgene in 1999 as its chief
financial officer, the company was a struggling biotech that sold just one product ae
a leprosy drug 4€ and faced a shaky future. By the time he stepped down as executive
chairman in February to run for United States Senate, Celgene had become a
pharmaceutical powerhouse with a market value of nearly $80
billion.,type:text}, {additions: [{URL:https://ir.celgene.com/press-
releases/press-release-details/2018/Celgene-Reports-Fourth-Quarter-and-Full-Year-2017
Operating-and-Financial-
Results/default.aspx, range: {length:17, start :177},type™:Link}],identifier™:
anf-body-7,inlineTextStyles: [{range™: {length:195,start:0},textStyle: anf-ts-
i}, {range™: {length:195,start:0},textStyle: anf-ts-1}],layout:default-
body, role:body, text:And that onetime leprosy drug? It had been transformed into
Revlimid, a best-selling cancer drug that, with annual sales of $8.2 billion, made up
nearly two-thirds of Celgened€™s net sales in
2017.,type™:text}, {additions™: [{URL:https://youtu.be/K4Agl kLfs5w, range: {len

gth:34,start:174},type™:link}],identifier: anf-body-

8, inlineTextstyles: [{range<:{length:324,start:0},textstyle: anf-ts-—
I}, {range™: {length:324,start:0},textStyle: anf-ts-1}],layout:default—
body, role: body, text:Mr. Hugin, a Republican mounting a surprisingly strong

challenge to Senator Robert Menendez in New Jersey, has made his career at Celgene a
cornerstone of his campaign, with television advertisements boasting that he d€cechose a
life of serviced€ in the Marines and a€eleading a health care company that develops

cancer medicine.a€, type: text}, {identifier: anf-body-
9,inlineTextStyles:[{range: {length:299,start:0},textsStyle: anf-ts-
i},{range™: {length:299,start:0},textStyle: anf-ts-1}],layout:default-

body, role: body, text:In deeply blue New Jersey, few expected a real contest for
Mr. Menendezad€™s seat. Yet anger stemming from Mr. Menendeza€™s federal corruption
trial last year 4€ a trial that Mr. Hugindé€™s campaign reminds television viewers in
New Jersey about on a regular basis a4€ has dampened his popularity among

voters.,type:text}, {bannerType™: any, identifier: anf-banner advertisement
i, layout: ComponentLayout-—
4,role:banner advertisement, type:banner advertisement}, {additions: [{URL™:h

ttps://twitter.com/realDonaldTrump/status/1016368503723577344, range: {length:21,st
art ™:213}, type™:link}, {URL:https://news.gallup.com/poll1/12748/business-industry-
sector-

ratings.aspx, range: {length:16, start :238},type™:link}],identifier: anf-
body-10, inlineTextStyles: [{range™: {length:413,start:0},textStyle: anf-ts-
I}, {range™: {length:413,start:0},textStyle: anf-ts-1}],layout:default—
body, role: body, text: But Mr. Hugind€™s professional career could also prove to

be a liability da4€ he is the sole pharmaceutical executive running for statewide office
in 2018. Anger over high drug prices has risen and President Trump has vilified the
industry. A 2017 Gallup poll found that just 33 percent of the country had a favorable

view of the drug industry, the second-lowest of any sector. (The lowest was the federal
government.),type:text}, {identifier: anf-body-
11i,inlineTextStyles: [{range:{length:394,start:0},textStyle: anf-ts-

HOUSE_OVERSIGHT_028415
